Your browser doesn't support javascript.
loading
A formula for predicting emphysema extent in combined idiopathic pulmonary fibrosis and emphysema.
Wells, Athol U; Jacob, Joseph; Sverzellati, Nicola; Cross, Gary; Barnett, Joseph; De Lauretis, Angelo; Antoniou, Katerina; Weycker, Derek; Atwood, Mark; Kirchgaessler, Klaus-Uwe; Cottin, Vincent.
Afiliación
  • Wells AU; Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK. RBHILD@rbht.nhs.uk.
  • Jacob J; Department of Respiratory Medicine, University College London, London, UK.
  • Sverzellati N; Satsuma Lab, Centre for Medical Image Computing, University College London, London, UK.
  • Cross G; Scienze Radiologiche, Department of Medicine and Surgery, University Hospital Parma, Parma, Italy.
  • Barnett J; Royal Free Hospital, London, UK.
  • De Lauretis A; Royal Free Hospital, London, UK.
  • Antoniou K; Department of Respiratory Medicine, University of Insubria, Ospedale di Circolo, Varese, Italy.
  • Weycker D; Interstitial Lung Disease Unit, Department of Thoracic Medicine, School of Medicine, University of Crete, Heraklion, Greece.
  • Atwood M; Policy Analysis Inc. (PAI), Brookline, MA, USA.
  • Kirchgaessler KU; Policy Analysis Inc. (PAI), Brookline, MA, USA.
  • Cottin V; F. Hoffmann-La Roche, Ltd., Basel, Switzerland.
Respir Res ; 25(1): 33, 2024 Jan 18.
Article en En | MEDLINE | ID: mdl-38238788
ABSTRACT

BACKGROUND:

No single pulmonary function test captures the functional effect of emphysema in idiopathic pulmonary fibrosis (IPF). Without experienced radiologists, other methods are needed to determine emphysema extent. Here, we report the development and validation of a formula to predict emphysema extent in patients with IPF and emphysema.

METHODS:

The development cohort included 76 patients with combined IPF and emphysema at the Royal Brompton Hospital, London, United Kingdom. The formula was derived using stepwise regression to generate the weighted combination of pulmonary function data that fitted best with emphysema extent on high-resolution computed tomography. Test cohorts included patients from two clinical trials (n = 455 [n = 174 with emphysema]; NCT00047645, NCT00075998) and a real-world cohort from the Royal Brompton Hospital (n = 191 [n = 110 with emphysema]). The formula is only applicable for patients with IPF and concomitant emphysema and accordingly was not used to detect the presence or absence of emphysema.

RESULTS:

The formula was predicted emphysema extent = 12.67 + (0.92 x percent predicted forced vital capacity) - (0.65 x percent predicted forced expiratory volume in 1 second) - (0.52 x percent predicted carbon monoxide diffusing capacity). A significant relationship between the formula and observed emphysema extent was found in both cohorts (R2 = 0.25, P < 0.0001; R2 = 0.47, P < 0.0001, respectively). In both, the formula better predicted observed emphysema extent versus individual pulmonary function tests. A 15% emphysema extent threshold, calculated using the formula, identified a significant difference in absolute changes from baseline in forced vital capacity at Week 48 in patients with baseline-predicted emphysema extent < 15% versus ≥ 15% (P = 0.0105).

CONCLUSION:

The formula, designed for use in patients with IPF and emphysema, demonstrated enhanced ability to predict emphysema extent versus individual pulmonary function tests. TRIAL REGISTRATION NCT00047645; NCT00075998.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfisema Pulmonar / Enfisema / Fibrosis Pulmonar Idiopática Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfisema Pulmonar / Enfisema / Fibrosis Pulmonar Idiopática Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article